His primary scientific interests are in Cancer research, Tumor suppressor gene, Pathology, Chromosomal translocation and Cytogenetics. Suresh C. Jhanwar combines subjects such as Cancer, Germline mutation and Gene rearrangement, Gene, Allele with his study of Cancer research. His study in Tumor suppressor gene is interdisciplinary in nature, drawing from both Locus, Neurofibromatosis type 2 and Point mutation.
His work carried out in the field of Pathology brings together such families of science as Fluorescence in situ hybridization and Leukemia. His studies in Chromosomal translocation integrate themes in fields like Molecular biology and Chromosome 17. His Cytogenetics research incorporates themes from Comparative genomic hybridization and Karyotype.
Suresh C. Jhanwar mostly deals with Pathology, Cancer research, Molecular biology, Genetics and Immunology. The various areas that he examines in his Pathology study include Fluorescence in situ hybridization, Karyotype and Cytogenetics. In Cancer research, Suresh C. Jhanwar works on issues like Retinoblastoma, which are connected to Mdm2.
His biological study spans a wide range of topics, including Cell culture and Southern blot, Chromosome, Gene, Chromosomal translocation. His Immunology study combines topics from a wide range of disciplines, such as Philadelphia chromosome and Oncology. Suresh C. Jhanwar has researched Leukemia in several fields, including Myeloid leukemia and Transplantation.
Suresh C. Jhanwar focuses on Cancer research, Pathology, Internal medicine, Oncology and Cancer. His Cancer research study integrates concerns from other disciplines, such as Mesothelioma, DNA methylation, Epidermal growth factor receptor, Carcinogenesis and Retinoblastoma. His Pathology study combines topics from a wide range of disciplines, such as Metastasis, Immunophenotyping, Cytogenetics, Fluorescence in situ hybridization and Leukemia.
His Cytogenetics research is multidisciplinary, relying on both Non-Hodgkin's lymphoma, Lymphoma, Disease and Karyotype. His Internal medicine research integrates issues from Gastroenterology and Surgery. The study incorporates disciplines such as Hepatocyte growth factor and Exon in addition to Cancer.
Suresh C. Jhanwar focuses on Cancer research, Fluorescence in situ hybridization, Pathology, Genetics and Melanoma. His Cancer research study integrates concerns from other disciplines, such as Epidermal growth factor receptor, Carcinogenesis, Mdm2, Molecular biology and Cell type. His Molecular biology research focuses on subjects like Regulation of gene expression, which are linked to Gene dosage.
Within one scientific family, he focuses on topics pertaining to Genome under Fluorescence in situ hybridization, and may sometimes address concerns connected to DNA sequencing, Exome sequencing and Double minute. His Pathology research includes elements of Stomach cancer, Real-time polymerase chain reaction, Concordance, Gene duplication and Adenocarcinoma. His research integrates issues of Dermatology, Comparative genomic hybridization and Anatomical pathology in his study of Melanoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BRCA1 mutations in primary breast and ovarian carcinomas
P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran.
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
Steven L. Soignet;Peter Maslak;Zhu-Gang Wang;Suresh Jhanwar.
The New England Journal of Medicine (1998)
Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus
Feihua Qiu;Prabir Ray;K. Brown;P. E. Barker.
The EMBO Journal (1988)
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
Steven J. Laken;Gloria M. Petersen;Stephen B. Gruber;Carole Oddoux.
Nature Genetics (1997)
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
James E. Butrynski;David R. D’Adamo;Jason L. Hornick;Paola Dal Cin.
The New England Journal of Medicine (2010)
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene: Implications for Presymptomatic Testing and Screening
Donna Shattuck Eidens;Melody Mcclure;Jacques Simard;Fernand Labrie.
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
E. De Alava;A. Kawai;J. H. Healey;I. Fligman.
Journal of Clinical Oncology (1998)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip;Alicia Pedraza;Debyani Chakravarty;Mohammad Azim.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
Kenneth Offit;Francesco Lo Coco;Francesco Lo Coco;Diane C. Louie;Nasser Z. Parsa.
The New England Journal of Medicine (1994)
MDM2 Gene Amplification in Metastatic Osteosarcoma
Marc Ladanyi;Charles Cha;Ronald Lewis;Suresh C. Jhanwar.
Cancer Research (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: